• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Impact of the 2008 US Preventive Services Task Force recommendation to discontinue prostate cancer screening among male Medicare beneficiaries.2008年美国预防服务工作组建议停止对老年医疗保险男性受益人群进行前列腺癌筛查的影响。
Arch Intern Med. 2012 Nov 12;172(20):1601-3. doi: 10.1001/archinternmed.2012.3726.
2
Long-term consequences of the USPSTF Grade D recommendation for prostate-specific antigen screening.美国预防服务工作组（USPSTF）对前列腺特异性抗原筛查的D级推荐的长期后果。
Cancer. 2020 Feb 15;126(4):694-696. doi: 10.1002/cncr.32605. Epub 2019 Dec 3.
3
2008 US Preventive Services Task Force recommendations and prostate cancer screening rates.2008年美国预防服务工作组建议与前列腺癌筛查率
JAMA. 2012 Apr 25;307(16):1692-4. doi: 10.1001/jama.2012.534.
4
Grading the new US Preventive Services Task Force prostate cancer screening recommendation.对美国预防服务工作组新的前列腺癌筛查建议进行分级。
JAMA. 2011 Dec 28;306(24):2715-6. doi: 10.1001/jama.2011.1893.
5
Evolving detection and treatment methods change approaches to prostate cancer: US Preventive Services Task Force draft recommendations now align more closely with others.不断发展的检测和治疗方法改变了前列腺癌的治疗方式：美国预防服务工作组的建议草案现在与其他建议更为一致。
Cancer. 2018 Jan 1;124(1):11-12. doi: 10.1002/cncr.31180.
6
Re: Prostate Cancer Incidence 5 Years After US Preventive Services Task Force Recommendations Against Screening.关于：美国预防服务工作组建议不进行筛查后5年的前列腺癌发病率
J Natl Cancer Inst. 2020 Oct 1;112(10):1067-1068. doi: 10.1093/jnci/djaa092.
7
Educational Material on Prostate Cancer Screening is Overly Complex and Fails to Meet Recommended Layperson Readability Guidelines.前列腺癌筛查教育材料过于复杂，未达到推荐的普通读者可读性指南要求。
Urology. 2020 Jan;135:1-3. doi: 10.1016/j.urology.2019.10.006. Epub 2019 Oct 24.
8
Impact of the United States Preventive Services Task Force 'D' recommendation on prostate cancer screening and staging.美国预防服务工作组“D”级推荐对前列腺癌筛查及分期的影响
Curr Opin Urol. 2017 May;27(3):205-209. doi: 10.1097/MOU.0000000000000383.
9
Prostate cancer incidence across stage, NCCN risk groups, and age before and after USPSTF Grade D recommendations against prostate-specific antigen screening in 2012.2012 年 USPSTF 发布 D 级前列腺特异性抗原筛查建议后，按阶段、NCCN 风险分组和年龄划分的前列腺癌发病率。
Cancer. 2020 Feb 15;126(4):717-724. doi: 10.1002/cncr.32604. Epub 2019 Dec 3.
10
Testing and referral patterns in the years surrounding the US Preventive Services Task Force recommendation against prostate-specific antigen screening.围绕美国预防服务工作组关于反对前列腺特异性抗原筛查建议的那些年里的检测和转诊模式。
Cancer. 2016 Dec 15;122(24):3785-3793. doi: 10.1002/cncr.30330. Epub 2016 Sep 22.

引用本文的文献

1
Disparities in Colorectal Cancer Screening Before and After the Onset of the COVID Pandemic.新冠疫情爆发前后结直肠癌筛查的差异
J Gen Intern Med. 2025 Feb;40(3):611-619. doi: 10.1007/s11606-024-09153-3. Epub 2024 Nov 4.
2
, , and : Novel Potential Biomarkers and Therapeutic Targets in Castration-Resistant Prostate Cancer.去势抵抗性前列腺癌的新型潜在生物标志物和治疗靶点。
Int J Mol Sci. 2019 Jun 8;20(11):2802. doi: 10.3390/ijms20112802.
3
A continuous fall of PSA use for prostate cancer screening among Brazilian doctors since 2001. Good or bad notice?自 2001 年以来，巴西医生在前列腺癌筛查中连续降低 PSA 的使用率。这是好消息还是坏消息？
Int Braz J Urol. 2019 May-Jun;45(3):478-485. doi: 10.1590/S1677-5538.IBJU.2018.0179.
4
Exnovation of Low Value Care: A Decade of Prostate-Specific Antigen Screening Practices.低价值医疗的摒弃：前列腺特异性抗原筛查实践十年。
J Am Geriatr Soc. 2019 Jan;67(1):29-36. doi: 10.1111/jgs.15591. Epub 2018 Oct 6.
5
The increase of stage, grading, and metastases in patients undergoing radical prostatectomy during the last decade.在过去十年中，接受根治性前列腺切除术的患者的分期、分级和转移增加。
World J Urol. 2019 Jun;37(6):1103-1109. doi: 10.1007/s00345-018-2487-0. Epub 2018 Sep 17.
6
Prostate cancer screening practices in a large, integrated health system: 2007-2014.大型综合医疗系统中的前列腺癌筛查实践：2007 - 2014年
BJU Int. 2017 Aug;120(2):257-264. doi: 10.1111/bju.13793. Epub 2017 Feb 26.
7
Prostate Cancer Screening: A Brief Tool to Incorporate Patient Preferences in a Clinical Encounter.前列腺癌筛查：在临床诊疗中纳入患者偏好的简要工具。
Front Oncol. 2016 Nov 4;6:235. doi: 10.3389/fonc.2016.00235. eCollection 2016.
8
Recent decline in prostate cancer incidence in the United States, by age, stage, and Gleason score.美国前列腺癌发病率近期按年龄、分期和 Gleason 评分的下降情况。
Cancer Med. 2016 Jan;5(1):136-41. doi: 10.1002/cam4.549. Epub 2015 Dec 2.
9
Pediatric screening urinalysis: a difference-in-differences analysis of how a 2007 change in guidelines impacted use.儿科筛查尿液分析：对2007年指南变更如何影响其使用的双重差分分析
BMC Pediatr. 2014 Oct 10;14:260. doi: 10.1186/1471-2431-14-260.
10
Is anyone listening? Variation in PSA screening among providers for men 75+ before and after United States Preventive Services Task Force recommendations against it: a retrospective cohort study.有人在听吗？在美国预防服务工作组建议反对对75岁及以上男性进行前列腺特异性抗原（PSA）筛查前后，不同医疗服务提供者之间PSA筛查情况的差异：一项回顾性队列研究。
PLoS One. 2014 Sep 10;9(9):e107352. doi: 10.1371/journal.pone.0107352. eCollection 2014.

本文引用的文献

1
Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.前列腺癌筛查：美国预防服务工作组推荐声明。
Ann Intern Med. 2012 Jul 17;157(2):120-34. doi: 10.7326/0003-4819-157-2-201207170-00459.
2
2008 US Preventive Services Task Force recommendations and prostate cancer screening rates.2008年美国预防服务工作组建议与前列腺癌筛查率
JAMA. 2012 Apr 25;307(16):1692-4. doi: 10.1001/jama.2012.534.
3
Prostate-specific antigen testing in older men in the USA: data from the behavioral risk factor surveillance system.美国老年男性前列腺特异性抗原检测：来自行为危险因素监测系统的数据。
BJU Int. 2012 Nov;110(10):1485-90. doi: 10.1111/j.1464-410X.2012.11013.x. Epub 2012 Mar 27.
4
Influence of publication of US and European prostate cancer screening trials on PSA testing practices.美国和欧洲前列腺癌筛查试验的发表对 PSA 检测实践的影响。
J Natl Cancer Inst. 2011 Mar 16;103(6):520-3. doi: 10.1093/jnci/djr007. Epub 2011 Feb 28.
5
Variation in prostate-specific antigen screening in men aged 80 and older in fee-for-service Medicare.80 岁及以上接受按服务收费的医疗保险的男性中前列腺特异性抗原筛查的变化。
J Am Geriatr Soc. 2010 Apr;58(4):674-80. doi: 10.1111/j.1532-5415.2010.02761.x. Epub 2010 Mar 22.
6
Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.前列腺癌筛查：美国预防服务工作组建议声明
Ann Intern Med. 2008 Aug 5;149(3):185-91. doi: 10.7326/0003-4819-149-3-200808050-00008.
7
PSA screening among elderly men with limited life expectancies.预期寿命有限的老年男性的前列腺特异性抗原（PSA）筛查。
JAMA. 2006 Nov 15;296(19):2336-42. doi: 10.1001/jama.296.19.2336.

Impact of the 2008 US Preventive Services Task Force recommendation to discontinue prostate cancer screening among male Medicare beneficiaries.

作者信息

Ross Joseph S, Wang Rong, Long Jessica B, Gross Cary P, Ma Xiaomei

出版信息

Arch Intern Med. 2012 Nov 12;172(20):1601-3. doi: 10.1001/archinternmed.2012.3726.

DOI:10.1001/archinternmed.2012.3726
PMID:22987029
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3597450/
Abstract
摘要